Search

Search Results

1. Gallbladder Cancer Current Treatment Options

   The book discusses the recent progress in understanding the therapeutic targets for gallbladder cancer to provide opportunities for research and for...

   Vijay Kumar Shukla, Manoj Pandey, Ruhi Dixit

   Book 2023
   

2. Local Therapeutics for the Treatment of Oligo Metastatic Prostate Cancer

   Purpose of Review

   Metastatic prostate cancer remains universally lethal. Although de-novo metastatic prostate cancer was historically managed with...

   Michael J. Jalfon, Om V. Sakhalkar, ... Isaac Y. Kim in Current Urology Reports

   Article 28 June 2023

3. Molecular explorations of cancer biology and therapeutics at PDB-101

   David S. Goodsell, Shuchismita Dutta, ... Stephen K. Burley in Oncogene

   Article Open access 10 August 2022
   

4. Therapeutic Approaches in Cancer Treatment

   This comprehensive book provides an overview of cancer therapeutics and covers different innovative treatment approaches for cancer. The initial...

   Asma Saleem Qazi, Kanwal Tariq in Cancer Treatment and Research

   Book 2023
   

5. Understanding on CRISPR/Cas9 mediated cutting-edge approaches for cancer therapeutics

   The research focus on CRISPR/Cas9 has gained substantial concentration since the discovery of ‘an unusual repeat sequence’ reported by Ishino et al....

   Rudrarup Bhattacharjee, Lopamudra Das Roy, Amarendranath Choudhury in Discover Oncology

   Article Open access 08 June 2022
   

6. Pancreatic Cancer Current Therapeutics and Future Directions

    

   Pancreatic cancer is a challenging and complex disease characterized by a dense fibrotic stroma and an immunosuppressive tumor...

   Shubham Pant

   Book 2023
   

7. Digital therapeutics from bench to bedside

   As a new therapeutic technique based on digital technology, the commercialization and clinical application of digital therapeutics (DTx) are...

   Changwon Wang, Chungkeun Lee, Hangsik Shin in npj Digital Medicine

   Article Open access 10 March 2023
   

8. TNFR2 antagonist and agonist: a potential therapeutics in cancer immunotherapy

   Tumour necrosis factor receptor 2 or TNFR2 is considered an appealing target protein due to its limited frequency to TREGs, which are highly...

   Sameer Quazi in Medical Oncology

   Article 29 September 2022
   

9. Clinical Characteristics, Diagnosis, and Therapeutics of COVID-19: A Review

   The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that suddenly emerged at the end of December 2019 and caused coronavirus...

   Na-na **e, Wen-cong Zhang, ... Jian-xin Song in Current Medical Science

   Article 14 October 2023

10. De-Escalation of Multidisciplinary Breast Cancer Care with Cryoablation Therapy: Navigating Novel Therapeutics, Ethics, and Outcomes

    Olivia Cheng, Lauren M. Postlewait in Annals of Surgical Oncology

    Article 07 January 2024

11. mRNA-based therapeutics: powerful and versatile tools to combat diseases

    The therapeutic use of messenger RNA (mRNA) has fueled great hope to combat a wide range of incurable diseases. Recent rapid advances in...

    Shugang Qin, **aoshan Tang, ... **angrong Song in Signal Transduction and Targeted Therapy

    Article Open access 21 May 2022
    

12. TGF-β signaling in health, disease, and therapeutics

    Transforming growth factor (TGF)-β is a multifunctional cytokine expressed by almost every tissue and cell type. The signal transduction of TGF-β can...

    Ziqin Deng, Tao Fan, ... Jie He in Signal Transduction and Targeted Therapy

    Article Open access 22 March 2024
    

13. Personalizing approaches to the management of metastatic hormone sensitive prostate cancer: role of advanced imaging, genetics and therapeutics

    Purpose

    To summarize contemporary and emerging strategies for the diagnosis and management of metastatic hormone sensitive prostate cancer (mHSPC),...

    Soum D. Lokeshwar, Ankur U. Choksi, ... Michael S. Leapman in World Journal of Urology

    Article 09 May 2023

14. NK Cell Therapeutics for Hematologic Malignancies: from Potential to Fruition

    Purpose of Review

    The current review focuses on the preclinical development and clinical advances of natural killer (NK) cell therapeutics for...

    Stephanie L. Fetzko, Leander D. Timothy, Robin Parihar in Current Hematologic Malignancy Reports

    Article 26 September 2023
    

15. TRAIL-mediated signaling in bladder cancer: realization of clinical efficacy of TRAIL-based therapeutics in medical oncology

    Bladder cancer is a therapeutically challenging disease and wealth of knowledge has enabled researchers to develop a clear understanding of...

    Ammad Ahmad Farooqi, Rakhmetova Venera, ... Assiya Turgambayeva in Medical Oncology

    Article 11 July 2023
    

16. Innovations in Skin and Soft Tissue Aging—A Systematic Literature Review and Market Analysis of Therapeutics and Associated Outcomes

    Purpose

    Skin and soft tissue aging has been an important topic of discussion among plastic surgeons and their patients. While botulinum toxin, facial...

    Sumun Khetpal, Durga Ghosh, Jason Roostaeian in Aesthetic Plastic Surgery

    Article Open access 08 May 2023
    

17. Nitro-fatty acids: mechanisms of action, roles in metabolic diseases, and therapeutics

    Nitro-fatty acids (NO ₂ -FAs) are a class of bioactive lipids that mediate metabolic, anti-oxidative stress, anti-inflammatory, and other signaling...

    Hui Ni, **n Tan, ... Yuan Wang in Current Medicine

    Article Open access 07 March 2024
    

18. Cancer vaccines as promising immuno-therapeutics: platforms and current progress

    Research on tumor immunotherapy has made tremendous progress in the past decades, with numerous studies entering the clinical evaluation. The cancer...

    Jian Liu, Minyang Fu, ... **awei Wei in Journal of Hematology & Oncology

    Article Open access 18 March 2022
    

19. Emerging therapeutics and evolving assessment criteria for intracranial metastases in patients with oncogene-driven non-small-cell lung cancer

    The improved survival outcomes of patients with non-small-cell lung cancer (NSCLC), largely owing to the improved control of systemic disease...

    Kelsey Pan, Kyle Concannon, ... **uning Le in Nature Reviews Clinical Oncology

    Article 17 August 2023
    

20. The immunomodulatory function and antitumor effect of disulfiram: paving the way for novel cancer therapeutics

    More than 60 years ago, disulfiram (DSF) was employed for the management of alcohol addiction. This promising cancer therapeutic agent inhibits...

    Sijia Zhang, Yan Zong, ... Rui Meng in Discover Oncology

    Article Open access 16 June 2023